Cortina Holdings Limited (SGX:C41)

Ligand Pharmaceuticals Ratios and Metrics

Market cap in millions SGD. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 1, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	629	452	538	621	662	368
Market Cap Growth	-16.00%	-16.00%	-13.33%	-6.25%	80.18%	85.00%
Enterprise Value	695	548	582	551	629	330
Last Close Price	3.80	2.73	3.09	3.42	3.54	1.92
PE Ratio	9.89	7.11	8.81	8.11	9.63	9.25
PS Ratio	0.73	0.52	0.66	0.75	0.92	0.84
PB Ratio	1.38	0.99	1.33	1.63	2.01	1.36
P/TBV Ratio	1.45	1.04	1.37	1.71	2.11	1.43
P/FCF Ratio	13.20	9.49	40.47	7.49	4.64	4.07
P/OCF Ratio	11.60	8.34	13.58	5.80	4.17	3.97
EV/Sales Ratio	0.81	0.64	0.72	0.67	0.88	0.76
EV/EBITDA Ratio	4.65	5.09	5.28	4.59	6.47	6.30
EV/EBIT Ratio	7.47	5.89	6.01	4.97	6.99	6.92
EV/FCF Ratio	14.59	11.50	43.81	6.64	4.41	3.65
Debt / Equity Ratio	0.39	0.39	0.36	0.32	0.44	0.51
Debt / EBITDA Ratio	1.19	1.19	1.00	0.81	1.11	1.81
Debt / FCF Ratio	3.75	3.75	11.05	1.49	1.01	1.51
Asset Turnover	1.19	1.19	1.21	1.34	1.31	1.04
Inventory Turnover	1.78	1.78	2.00	2.50	2.27	1.74
Quick Ratio	0.84	0.84	0.65	1.06	1.48	0.97
Current Ratio	2.86	2.86	2.17	2.48	2.81	2.43
Return on Equity (ROE)	16.27%	16.27%	17.09%	23.49%	24.64%	16.81%
Return on Assets (ROA)	8.00%	8.00%	9.03%	11.19%	10.29%	7.12%
Return on Capital (ROIC)	9.79%	9.79%	11.45%	14.15%	12.79%	8.54%
Return on Capital Employed (ROCE)	16.30%	16.30%	19.70%	23.50%	20.70%	13.70%
Earnings Yield	10.11%	14.07%	11.34%	12.32%	10.38%	10.81%
FCF Yield	7.57%	10.54%	2.47%	13.36%	21.55%	24.57%
Dividend Yield	4.31%	0.73%	0.65%	0.58%	0.56%	1.04%
Payout Ratio	5.21%	5.21%	5.42%	4.33%	4.82%	25.00%
Total Shareholder Return	4.31%	0.73%	0.65%	0.58%	0.56%	1.04%

Updated Nov 12, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.